Genomics has the ability to transform our understanding of cancer, providing researchers with increasingly complex information on tumour heterogeneity and […]
Peter Johnson, National Clinical Director for Cancer, NHS England
Drug discovery is a time-consuming and costly process, particularly given the high number of trials that ultimately “fail” or have […]
In a healthy individual, the immune system responds to “foreign” cells (such as cancer) by attacking and eliminating them. Unfortunately, […]
We’ve come a long way since the dawn of Sanger sequencing in 1977. The rapid development of next-generation sequencing (NGS) […]
Cancer is a disease of the genome. Environmental factors can certainly influence the growth and spread of cancer, but the […]
According to the British Journal of Cancer, one in two of us will develop cancer in our lifetime. Despite this […]
Liquid biopsy has seen a lot of development and many applications in the field of cancer diagnostics. Key applications include […]
Detecting early signs of disease is often crucial to achieving the best possible patient outcomes. To date, blood-based liquid biopsies have […]
Andy Sharrocks (Professor at The University of Manchester) joins us to discuss the epigenetics of esophageal adenocarcinoma, why studying epigenetics […]
